Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Accelerator depth dose testing measures the central-axis percentage depth dose (PDD) and electron depth-dose distribution of linear accelerators in water phantoms, verifying beam energy, beam quality, and dosimetric performance in accordance with IEC 60976, IAEA TRS-398, and AAPM TG-51. Accredited third-party laboratories and medical physics teams rely on these measurements for acceptance testing, commissioning, quality assurance, and regulatory compliance of radiotherapy and industrial electron beam accelerators.

Technical Overview

Accelerator depth dose testing is the measurement and evaluation of how absorbed dose varies along the central axis of a radiation beam as it penetrates a water or water-equivalent medium. For photon beams, the resulting percentage depth dose (PDD) curve exhibits a characteristic build-up region, a depth of maximum dose (dmax), and an exponential attenuation tail. For electron beams, the curve shows a rapid fall-off after the therapeutic range, defined by parameters such as R50 (depth at 50% of maximum dose), R90, and the practical range Rp.

Depth dose data are the foundation of clinical reference dosimetry and treatment planning. Modern protocols such as IAEA TRS-398 and AAPM TG-51 use measured depth dose parameters (for example, PDD(10) or the quality index TPR20,10 for photons, and R50 for electrons) to select beam quality correction factors kQ and to derive the most probable and mean electron energies. Consequently, any error in the depth dose distribution propagates directly into the absorbed dose delivered to patients or processed products.

Testing is typically performed with a computer-controlled three-dimensional water phantom using calibrated ionization chambers, following the functional performance test methods described in IEC 60976 and IEC 60977, with basic safety requirements covered by IEC 60601-2-1 and its Chinese national adoption GB 9706.201. For industrial electron beam accelerators, depth dose distributions in unit-density phantoms are measured under ISO/ASTM 51649 to determine penetration, practical range, and optimum irradiation thickness.

Testing Samples

Medical Linear Accelerators – Photon Beams

Isocentric medical linear accelerators generating megavoltage photon beams, typically in the range of 4 MV to 25 MV, including conventional C-arm LINACs with flattened beams, flattening-filter-free (FFF) modes, and matched dual-energy units. Depth dose testing verifies the nominal accelerating potential and the consistency of PDD curves across all energies, field sizes, and wedge modes.

Medical Electron Accelerators – Electron Beams

Electron treatment modes from approximately 4 MeV to 25 MeV, used for skin lesions, breast boost, intraoperative radiotherapy, and total skin electron techniques. Testing focuses on R50, practical range Rp, therapeutic range R90, surface dose, and bremsstrahlung (X-ray) contamination beyond Rp.

Industrial Electron Beam Accelerators

DC and RF electron accelerators in the 300 keV to 25 MeV range used for radiation crosslinking of polymers, sterilization of medical devices, and food irradiation. Depth dose profiles in wedge or stacked phantoms establish beam penetration, energy, and the optimum product thickness for single- or double-sided irradiation.

Re-Commissioned, Repaired, or Type-Tested Units

Accelerators undergoing factory type testing, site acceptance testing after installation, or re-verification following major servicing such as replacement of the gun, waveguide, bending magnet, target, or flattening filter, all of which can shift beam energy and alter depth dose characteristics.

Testing Items

Core measurement items evaluated during accelerator depth dose testing include:

  • Percentage depth dose (PDD) curves on the central axis for all photon energies at reference geometry (10 cm × 10 cm field, 100 cm SSD) and for selected clinically relevant field sizes.
  • Depth of ionization maximum (dmax) and reference depth (dref) determination for each beam.
  • PDD at 10 cm depth, PDD(10) or PDD(20,10), and the beam quality index TPR20,10 required by IAEA TRS-398 and AAPM TG-51 for kQ selection.
  • Electron beam parameters: R50, R90, R85, practical range Rp, and the derived mean energy at the phantom surface, E0 = 2.33 × R50 (MeV), and most probable energy, Ep,0 = 0.22 + 1.98 Rp + 0.0025 Rp².
  • Surface dose and build-up region characterization, including skin-sparing assessment for photons and the high surface dose of electron beams.
  • Bremsstrahlung contamination of electron beams, evaluated from the photon tail beyond Rp relative to dmax.
  • Comparison of measured depth dose data with manufacturer specifications and baseline commissioning data, with agreement typically judged against ±2% or ±2 mm acceptance criteria.
  • Short-term reproducibility of depth dose parameters (R50, dmax, PDD(10)) to demonstrate dosimetric stability.

Testing Methods

3D Water Phantom Scanning with Ionization Chambers

The reference method uses a motorized three-dimensional scanning water tank with positioning reproducibility better than 0.2 mm. A small-volume cylindrical ionization chamber (typically 0.01–0.13 cm³) scans the central axis in depth increments of 1 mm or finer. Measurements are corrected for temperature, pressure, polarity, and recombination, and the detector is positioned at its effective point of measurement (0.5–0.6 of the cavity radius upstream for cylindrical chambers; at the inner window surface for parallel-plate chambers). Parallel-plate chambers are mandatory for electron beams below approximately 10 MeV and for build-up region measurements.

Reference Dosimetry Protocols

Absorbed dose at the reference depth is determined per IAEA TRS-398 (calibration in water at 10 cm depth for photons; at zref = 0.6 R50 − 0.1 cm for electrons) or AAPM TG-51, using a chamber with a 60Co absorbed-dose to water calibration coefficient and the appropriate beam quality correction factor kQ. Dosimeter performance must meet the requirements of IEC 60731 and IEC 61674.

Film, Diode, and 2D Array Methods

Radiochromic film in solid water-equivalent phantoms provides high spatial resolution for build-up regions and small fields, and is the standard detector in industrial wedge phantoms. Silicon diodes and diamond detectors offer excellent spatial resolution for scanning but require energy-dependence corrections. 2D detector arrays and electronic portal imaging devices (EPID) are used for routine constancy checks of depth dose–related quality parameters, with water phantom measurements remaining the reference.

Industrial Electron Beam Depth-Dose Measurement

Per ISO/ASTM 51649, dosimetry films, alanine dosimeters read by EPR (ISO/ASTM 51607), or routine dosimetry systems calibrated under ISO/ASTM 51261 are interleaved in wedge or stacked phantoms of unit density. The resulting depth-dose profile yields practical range, optimum thickness (dose at exit ≥ dose at entrance), and beam energy for radiation processing qualification.

Applications

Accelerator depth dose testing supports the complete equipment lifecycle:

  • Site acceptance testing and commissioning of new medical LINACs, providing beam data for treatment planning systems in line with AAPM TG-106 and IEC 60976 type test methods.
  • Annual and post-repair quality assurance verifying that beam energy and quality indices remain within tolerance of baseline data, consistent with AAPM TG-40 and IAEA human health publications.
  • Regulatory registration, market approval, and factory type testing of medical electron accelerators against IEC 60976/60977 and national requirements such as GB 9706.201 and associated GB/YY standards.
  • Independent dosimetry audits and inter-laboratory comparisons for radiotherapy networks.
  • Qualification of industrial e-beam facilities for polymer crosslinking, sterilization, and food applications, establishing process parameters and maximum product thickness.
  • Research applications, including Monte Carlo beam model validation and development of new treatment techniques.

FAQ

Question: How often should accelerator depth dose testing be performed?

Answer: Full PDD and electron R50 measurements are required at commissioning and annually thereafter, and additionally after any event that may alter beam energy, such as waveguide, gun, or target replacement, or relocation of the accelerator. Condensed energy checks based on depth dose parameters are performed monthly at most radiotherapy centers.

Question: Why is a water phantom used as the reference medium?

Answer: Water is the ICRU reference medium for radiotherapy dosimetry because it closely mimics the radiation attenuation and scattering properties of human soft tissue, and because IAEA TRS-398 and AAPM TG-51 calibration coefficients and quality correction factors are defined for water measurements.

Question: What are typical acceptance criteria for depth dose results?

Answer: Measured PDD curves are generally required to agree with baseline or manufacturer data within ±2% in the low-gradient region or ±2 mm in depth in the penumbral fall-off region; electron R50 tolerances of ±1–2 mm are commonly applied, alongside the functional performance tolerances declared by the manufacturer per IEC 60976.

Question: Can solid phantoms replace water for routine measurements?

Answer: Solid water-equivalent and PMMA phantoms are acceptable for constancy checks when appropriate conversion factors and consistent setup are used, but water phantom measurements remain the reference standard for absolute beam quality determination and any measurement used for dose calibration.

Question: How is electron energy determined from the depth dose curve?

Answer: The mean energy at the phantom surface is calculated as E0 = 2.33 × R50, and the most probable energy from the practical range Rp using Ep,0 = 0.22 + 1.98 Rp + 0.0025 Rp², as specified in IAEA TRS-398. For example, a typical 6 MeV beam yields R50 of about 2.3 cm and an 18 MeV beam about 7.5 cm.

Question: Who can perform accredited depth dose testing?

Answer: Testing should be carried out by qualified medical physicists or accredited third-party laboratories equipped with calibrated reference-class dosimeters, 3D water scanning systems, and traceability to national standards of absorbed dose to water.